Log In
Print
BCIQ
Print
Print this Print this
 

Prochymal, remestemcel-L

  Manage Alerts
Collapse Summary General Information
Company Osiris Therapeutics Inc.
DescriptionIV formulation of mesenchymal stem cells (MSCs)
Molecular Target Not applicable
Mechanism of ActionImmune modulation
 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of Development
More More
 Archive Items are loading loading
Get a free BioCentury trial today